Hep C Infection Poses Global Public Health Threat to Reproductive-Age Women
By Lori Solomon HealthDay Reporter
WEDNESDAY, May 15, 2024 -- Both acute hepatitis C (AHC) and hepatitis C virus (HCV)-related cirrhosis incidence were up substantially globally from 1990 to 2019 in reproductive-aged women, according to a study published online April 19 in the Journal of Global Health.
Yanzheng Zou, from the School of Public Health at Nanjing Medical University in China, and colleagues used data from the Global Burden of Disease study to examine the global incidence and temporal trends (1990 to 2019) of AHC and HCV-related cirrhosis among women of reproductive age (15 to 49 years).
The researchers found that during the study period, global incidences of AHC and HCV-related cirrhosis increased by 46.45 percent and 72.74 percent, respectively. In low sociodemographic index regions, the age-standardized incidence rates of AHC were highest, but showed a declining trend, while age-standardized incidence rates of HCV-related cirrhosis showed unfavorable trends in low, low-middle, and high sociodemographic index regions. High incidence rates or increasing trends of AHC and HCV-related cirrhosis were seen in sub-Saharan Africa, high-income North America, Eastern Europe, and Central Asia.
"Period effects suggested a resurgence in the risk of AHC and HCV-related cirrhosis in recent years, posing further challenges for HCV elimination," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Higher Hepatitis C Virus Cure Rates Seen With Facilitated Telemedicine
FRIDAY, April 12, 2024 -- Significantly higher hepatitis C virus cure rates are seen for patients receiving opioid treatment program-integrated facilitated telemedicine versus...
Prevalence of Hepatitis Delta High in Hepatitis B Surface Antigen Chronic Carriers
THURSDAY, April 4, 2024 -- The prevalence of hepatitis delta virus (HDV) is high in hepatitis B surface antigen (HBs Ag) chronic carriers detected through annual screenings...
Guideline Updated for Managing Hepatitis C in Chronic Kidney Disease
TUESDAY, Dec. 12, 2023 -- The Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on prevention, diagnosis, evaluation, and treatment of hepatitis C in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.